Citations

Clear

904 citation(s) found for "Gordon, S".

Effects of anomalous language representation on neuropsychological performance in temporal lobe epilepsy
Strauss, Eva von , Perrine, Kenneth , Trenerry, Max R., Westerveld, Michael, Chelune, Gordon J. , Lee, G.P., Loring, David W. , Hermann, Bruce P. , Barr, William , Meador, Kimford J.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 53 | Issue: 2 | Pages: 260-260

10.1212/wnl.53.2.260 | PMID 10430411 Get It

The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro
Windebank, Anthony J. , Smith, A. Gordon , Russell, James W.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 44 | Issue: 3_part_1 | Pages: 488-488

10.1212/wnl.44.3_part_1.488 | PMID 8145920 Get It

Failure of inactivation of Duchenne dystrophy X‐chromosome in one of female identical twins
Gómez, Manuel R., Engel, Andrew G. , Dewald, Gordon W., Peterson, Hamlet A.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 27 | Issue: 6 | Pages: 537-537

10.1212/wnl.27.6.537 | PMID 559260 Get It

The syndrome of systemic carnitine deficiency
Karpati, George, Carpenter, Stirling, Engel, Andrew G. , Watters, Gordon V., Rothman, Stanley, Klassen, Gerald A., Mamer, Orval, Allen, Jeffrey C.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 25 | Issue: 1 | Pages: 16-16

10.1212/wnl.25.1.16 | PMID 234182 Get It

The abnormal aminoaciduria in petit mal epilepsy
Jones, James D., Etheridge, James E., Millichap, J Gordon

Mayo Clinic

Neurology | May 13, 2012 | Volume: 16 | Issue: 6 | Pages: 569-569

10.1212/wnl.16.6.569 | PMID 4957014 Get It

The electroencephalogram in children with intracranial tumors and seizures
Bickford, Reginald G., Miller, Ross H. , Backus, Reno E., Millichap, J Gordon

Mayo Clinic

Neurology | May 13, 2012 | Volume: 12 | Issue: 5 | Pages: 329-329

10.1212/wnl.12.5.329 Get It

Emerging synaptic biomarkers in autoimmune dementia
Pittock, Sean J. , Balice‐Gordon, Rita J. , Pittock, S J

Mayo Clinic

Neurology | April 27, 2012 | Volume: 78 | Issue: 22 | Pages: 1710-1711

10.1212/wnl.0b013e31825830f3 | PMID 22539567 Get It

Guidelines for Preventing and Treating Vitamin D Deficiency and Insufficiency Revisited
Holick, Michael F. , Binkley, Neil , Bischoff‐Ferrari, Heike A. , Gordon, Catherine M. , Hanley, David A. , Heaney, Robert P., Murad, M. Hassan , Weaver, Connie M. , Murad, M Hassan

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 23, 2012 | Volume: 97 | Issue: 4 | Pages: 1153-1158

10.1210/jc.2011-2601 | PMID 22442274 Get It

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Lohr, Jens G. , Stojanov, Petar, Auclair, Daniel , Chapuy, Bjoern , Sougnez, Carrie, Cruz‐Gordillo, Peter , Knoechel, Birgit , Asmann, Yan W. , Novak, Anne J. , Ansell, Stephen M. , Link, Brian K. , Zou, Lihua , Gould, Joshua , Saksena, Gordon , Stransky, Nicolas , Rangel‐Escareño, Claudia , Fernández-López, Juan Carlos , Hidalgo‐Miranda, Alfredo , Meléndez-Zajgla, Jorge , Hernández–Lemus, Enrique , Celis, Angela Schwarz‐Cruz y, Imaz-Rosshandler, Iván , Ojesina, Akinyemi I. , Jung, Joonil, Pedamallu, Chandra Sekhar , Lander, Eric S. , Cerhan, James R. , Golub, Todd R. , Lawrence, Michael S. , Slager, Susan L. , Doǧan, Ahmet , Habermann, Thomas M. , Shipp, Margaret Ann , Getz, Gad , Cerhan, James R , Link, Brian K

Mayo Clinic

Proceedings of the National Academy of Sciences | February 18, 2012 | Volume: 109 | Issue: 10 | Pages: 3879-3884

10.1073/pnas.1121343109 | PMID 22343534 Get It

To gain insight into the genomic basis of diffuse large B-cell lymphoma (DLBCL), we performed massively parallel whole-exome sequencing of 55 primary tumor samples from patients with DLBCL and matched normal tissue. We identified recurrent mutations in genes that are well known to be functionally relevant in DLBCL, including MYD88 , CARD11 , EZH2 , and CREBBP . We also identified somatic mutations in genes for which a functional role in DLBCL has not been previously suspected. These genes include MEF2B , MLL2 , BTG1 , GNA13 , ACTB , P2RY8 , PCLO , and TNFRSF14 . Further, we show that BCL2 mutations commonly occur in patients with BCL2 / IgH rearrangements as a result of somatic hypermutation normally occurring at the IgH locus. The BCL2 point mutations are primarily synonymous, and likely caused by activation-induced cytidine deaminase–mediated somatic hypermutation, as shown by comprehensive analysis of enrichment of mutations in WRCY target motifs. Those nonsynonymous mutations that are observed tend to be found outside of the functionally important BH domains of the protein, suggesting that strong negative selection against BCL2 loss-of-function mutations is at play. Last, by using an algorithm designed to identify likely functionally relevant but infrequent mutations, we identify KRAS , BRAF , and NOTCH1 as likely drivers of DLBCL pathogenesis in some patients. Our data provide an unbiased view of the landscape of mutations in DLBCL, and this in turn may point toward new therapeutic strategies for the disease.
Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493)
Wiernik, Peter H. , Li, Hailun , Weller, Edie, Höchster, Howard S. , Horning, Sandra J., Nazeer, Tipu, Gordon, Leo I. , Minniti, Carl J., Shapiro, Gary R., Cassileth, Peter A., Habermann, Thomas M. , Gordon, Leo I

Mayo Clinic

Leukemia & Lymphoma | January 11, 2012 | Volume: 53 | Issue: 6 | Pages: 1137-1142

10.3109/10428194.2011.643406 | PMID 22111940 Get It